Follow The Filings

INCY Incyte

Incyte earnings company data as of 3:58 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by INCY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INCY insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $58.3M sold by 10 insiders under 10b5-1 plans
  1. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $298K 2,642 shares at $112.71 1.4% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $2.8M 23,218 shares at $120.49 11% of stake
    Traded Sep 15 Filed Sep 17
    ↗
  3. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $1.4M 10,801 shares at $125.56 5.6% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  4. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $1.3M 10,803 shares at $120.04 5.3% of stake
    Traded Aug 12 Filed Aug 14
    ↗
  5. Patrick A Mayes EVP & Chief Scientific Officer
    Planned sale
    $274K 2,207 shares at $123.99 3.5% of stake
    Traded Aug 5 Filed Aug 7
    ↗
  6. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $1.3M 10,640 shares at $122.69 4.9% of stake
    Traded Aug 5 Filed Aug 7
    ↗
  7. Patrick A Mayes EVP & Chief Scientific Officer
    Planned sale
    $5.7M 47,954 shares at $119.58 44% of stake
    Traded Jul 31–Aug 3 Filed Aug 4
    ↗
  8. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $1.9M 15,888 shares at $119.70 6.9% of stake
    Traded Jul 31 Filed Aug 4
    ↗
  9. Mohamed Khairie Issa EVP, Head of U.S. Commercial
    Planned sale
    $126K 1,093 shares at $115.01 1.7% of stake
    Traded Jul 16 Filed Jul 20
    ↗
  10. Steven H Stein CMO & Head of Late-Stage Dev.
    Planned sale
    $215K 1,877 shares at $114.73 8.2% of stake
    Traded Jul 16 Filed Jul 20
    ↗
  11. Steven H Stein CMO & Head of Late-Stage Dev.
    Planned sale
    $3.2M 28,237 shares at $113.05 52% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  12. Thomas Tray Principal Accounting Officer
    Planned sale
    $264K 2,639 shares at $100.00 11% of stake
    Traded Jun 4 Filed Jun 8
    ↗
  13. Thomas Tray Principal Accounting Officer
    Planned sale
    $200K 2,051 shares at $97.35 8.8% of stake
    Traded May 26 Filed May 28
    ↗
  14. Paul J Clancy Director
    Planned sale
    $1.4M 15,000 shares at $94.93 39% of stake
    Traded May 19 Filed May 21
    ↗
  15. Pablo J Cagnoni President, Global Head of R&D
    Planned sale
    $1.8M 18,667 shares at $96.50 6.6% of stake
    Traded Apr 17 Filed Apr 21
    ↗

Also filed in the last 12 months, not counted as buying or selling: 44 option exercises, 41 stock grants, and 28 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 4 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.